The specialist drug development Company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases has noted that a multi-centre analysis of DNA samples from patients with severe forms of Covid-19, including symptoms caused by the over-active inflammatory response or "cytokine storm", has identified TYK2 as a key causative genetic mechanism and a potential target for therapy. This observation, which was published online as an Accelerated Article Pr ....
